Prothena (NASDAQ: [[ticker:PRTA]]) has named Gene Kinney as its chief operating officer, a new position at the drug developer. Kinney has been chief scientific officer and head of R&D since the company launched in 2012. He will keep those titles. Prothena is domiciled in Dublin, Ireland, but conducts daily operations in South San Francisco, CA.
Author: Alex Lash
I've spent nearly all my working life as a journalist. I covered the rise and fall of the dot-com era in the second half of the 1990s, then switched to life sciences in the new millennium. I've written about the strategy, financing and scientific breakthroughs of biotech for The Deal, Elsevier's Start-Up, In Vivo and The Pink Sheet, and Xconomy.
View all posts by Alex Lash
